<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03543956</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2018/09</org_study_id>
    <nct_id>NCT03543956</nct_id>
  </id_info>
  <brief_title>Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of Exposition</brief_title>
  <acronym>VISSEXPOSITION</acronym>
  <official_title>Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of Exposition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic Sclerosis (SSc) is an inflammatory chronic disease that can lead to structural
      damage and handicap. The SSc physiopathology is multifactorial, including genetic and
      environmental risk factors. The identification of environmental factors implication is
      crucial to understand the SSc mechanism, and improves the diagnosis and the treatment of the
      disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies show that the risk associated with high cumulative exposure to silica and organic
      solvents appears to be strongly increased in SSc. Moreover, exposure to silica is associated
      with a specific type of SSc phenotype with a worse prognosis. However, the type, intensity
      and probability of these expositions are unknown.

      The aim of the study is to precisely determine type, intensity and probability of toxic
      substances exposition in Systemic Sclerosis patients through an auto-questionnaire and
      integration of these data in a computer matrix.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2018</start_date>
  <completion_date type="Actual">June 27, 2019</completion_date>
  <primary_completion_date type="Actual">June 27, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analyse type, intensity and probability of toxic substances exposition in Systemic Sclerosis patients through an auto-questionnaire and integration of these data in a computer matrix</measure>
    <time_frame>At baseline (day 0)</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">226</enrollment>
  <condition>Systemic Sclerosis</condition>
  <arm_group>
    <arm_group_label>Systemic Sclerosis patient</arm_group_label>
    <description>patients affected by SSc according to EULAR 2013 criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Questionnaire</description>
    <arm_group_label>Systemic Sclerosis patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients affected by SSc according to EULAR 2013 criteria.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged over 18 years old

          -  Speaking and understanding French language

          -  Being informed about the study and having given his consent

          -  Affected by SSc according to EULAR 2013 criteria

        Exclusion Criteria:

          -  Patient under tutorship

          -  Patient who refuse to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Elise TRUCHETET, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU - Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Bordeaux - service de rhumatologie</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 18, 2018</study_first_submitted>
  <study_first_submitted_qc>May 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>September 10, 2019</last_update_submitted>
  <last_update_submitted_qc>September 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Silica</keyword>
  <keyword>Organic Solvents</keyword>
  <keyword>Toxic substances exposure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

